Anti-APPL antibody [EPR13569]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(10 Publications)
Rabbit Recombinant Monoclonal APPL antibody. Suitable for WB, ICC/IF, IHC-P and reacts with Human samples. Cited in 10 publications.
View Alternative Names
APPL, DIP13A, KIAA1428, APPL1, DCC-interacting protein 13-alpha, Dip13-alpha
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-APPL antibody [EPR13569] (AB180140)
Immunohistochemical analysis of paraffin-embedded Human colon carcinoma tissue labeling APPL with ab180140 at 1/100 dilution. Secondary antibody Goat anti rabbit IgG(HRP) prediluted. Counter stain Hematoxylin.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-APPL antibody [EPR13569] (AB180140)
Immunofluorescent analysis of 4% paraformaldehyde fixed MCF7 cells labeling APPL with ab180140 at 1/500 dilution. Secondary antibody Goat anti rabbit IgG(Dylight 555) Conterstained with Dapi blue.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-APPL antibody [EPR13569] (AB180140)
Immunohistochemical analysis of paraffin-embedded Human pancreas carcinoma tissue labeling APPL with ab180140 at 1/100 dilution. Secondary antibody Goat anti rabbit IgG(HRP) prediluted. Counter stain Hematoxylin.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-APPL antibody [EPR13569] (AB180140)
Lanes 1- 4 : Merged signal (red and green). Green - ab180140 observed at 90 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab180140 was shown to react with Anti-APPL in wild-type HeLa cells in western blot. The band observed in knockout cell line ab265187 (knockout cell lysate ab257836) lane below 90kDa may represent truncated forms and cleaved fragments. This has not been investigated further. Wild-type HeLa and APPL1 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab180140 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at a 1 in 10000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-APPL antibody [EPR13569] (ab180140) at 1/10000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
APPL knockout HeLa cell lysate at 20 µg
Lane 3:
MCF7 cell lysate at 20 µg
Lane 4:
HEK-293T cell lysate at 20 µg
Predicted band size: 80 kDa
Observed band size: 90 kDa
false
- WB
Supplier Data
Western blot - Anti-APPL antibody [EPR13569] (AB180140)
All lanes:
Western blot - Anti-APPL antibody [EPR13569] (ab180140) at 1/10000 dilution
Lane 1:
HeLa cell lysate at 20 µg
Lane 2:
MCF7 cell lysate at 20 µg
Lane 3:
293 cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 80 kDa
Observed band size: 90 kDa
false
- WB
Lab
Western blot - Anti-APPL antibody [EPR13569] (AB180140)
Lanes 1- 4 : Merged signal (red and green). Green - ab180140 observed at 90 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab180140 was shown to react with Anti-APPL in wild-type HeLa cells in western blot. The band observed in CRISPR/Cas9 edited cell line ab265187 (CRISPR/Cas9 edited cell lysate ab257836) lane below 90kDa may represent truncated forms and cleaved fragments. This has not been investigated further. Wild-type HeLa and APPL1 CRISPR/Cas9 edited HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab180140 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at a 1 in 10000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-APPL antibody [EPR13569] (ab180140) at 1/10000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
APPL CRISPR/Cas9 edited HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human APPL1 (APPL) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-appl1-appl-knockout-hela-cell-line-ab265187'>ab265187</a>)
Lane 3:
MCF7 cell lysate at 20 µg
Lane 4:
HEK-293T cell lysate at 20 µg
Predicted band size: 80 kDa
Observed band size: 90 kDa
false
Related conjugates and formulations (1)
-
Anti-APPL antibody [EPR13569] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
APPL1 influences cellular processes such as endocytosis and cell proliferation. APPL1 interacts with rab5 forming a component of endosomal signaling complexes. This interaction drives the early endocytic process influencing cell surface receptor trafficking. APPL1 also modulates insulin signaling by binding to proteins like the insulin receptor substrate affecting glucose metabolism and cellular energy balance.
Pathways
APPL1 acts in the AKT signaling pathway and the adiponectin signaling pathway. In the AKT pathway APPL1 operates with proteins like AKT itself and GSK3β contributing to cell survival and growth. It assists the adiponectin pathway by facilitating interactions between adiponectin receptors and downstream effectors impacting lipid metabolism and insulin sensitivity. APPL1's involvement in these pathways highlights its multifaceted regulatory roles in cellular metabolism and response to stimuli.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (10)
Recent publications for all applications. Explore the full list and refine your search
Neural regeneration research 19:863-871 PubMed37843222
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 299:104823 PubMed37187293
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2023:5885203 PubMed36846720
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular life sciences : CMLS 79:488 PubMed35984564
2022
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2021:7158444 PubMed34887998
2021
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 9:9 PubMed29335016
2018
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 40:1869-1880 PubMed29039441
2017
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 7:7497 PubMed28790390
2017
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 14:2137-2140 PubMed28789439
2017
Applications
Unspecified application
Species
Unspecified reactive species
Traffic (Copenhagen, Denmark) 9:2236-52 PubMed18939958
2008
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com